R. Cheng

618 total citations
15 papers, 508 citations indexed

About

R. Cheng is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, R. Cheng has authored 15 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in R. Cheng's work include Lung Cancer Research Studies (4 papers), RNA Interference and Gene Delivery (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). R. Cheng is often cited by papers focused on Lung Cancer Research Studies (4 papers), RNA Interference and Gene Delivery (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). R. Cheng collaborates with scholars based in China, United States and Spain. R. Cheng's co-authors include Wanda Chan, Armando Barreto, E. Μ. Convey, Bridget Butler, H. D. Durst, Peter A. Emanuel, Keat Khim Ong, Donald A. Tomalia, Ruoyu Yin and Susan P.C. Cole and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Endocrinology.

In The Last Decade

R. Cheng

14 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Cheng China	8	265	179	129	105	81	15	508
Ramona A. Silvestre Spain	19	335 1.3×	208 1.2×	338 2.6×	172 1.6×	522 6.4×	45	942
Takako Kakehi Japan	11	100 0.4×	47 0.3×	306 2.4×	133 1.3×	155 1.9×	14	467
Ranjev Bhogal United Kingdom	12	152 0.6×	70 0.4×	495 3.8×	53 0.5×	124 1.5×	19	724
Odette Morin Canada	12	97 0.4×	31 0.2×	281 2.2×	84 0.8×	201 2.5×	22	681
A Ardizzoia Italy	12	42 0.2×	123 0.7×	94 0.7×	61 0.6×	38 0.5×	31	421
Ranran Zhou China	9	35 0.1×	17 0.1×	80 0.6×	61 0.6×	61 0.8×	28	326
Rania Abu‐Hamdah United States	11	199 0.8×	27 0.2×	289 2.2×	100 1.0×	142 1.8×	12	545
Nicholas H. F. Fine United Kingdom	12	107 0.4×	16 0.1×	220 1.7×	85 0.8×	141 1.7×	16	520
Stephen C. Harmer United Kingdom	16	77 0.3×	24 0.1×	418 3.2×	18 0.2×	97 1.2×	37	665

Countries citing papers authored by R. Cheng

Since Specialization

Citations

This map shows the geographic impact of R. Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Cheng more than expected).

Fields of papers citing papers by R. Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Cheng. The network helps show where R. Cheng may publish in the future.

Co-authorship network of co-authors of R. Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of R. Cheng. A scholar is included among the top collaborators of R. Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Cheng. R. Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Wang, Jiaxin, et al.. (2025). Spatiotemporal Changes and Trade-Offs/Synergies of Waterfront Ecosystem Services Globally. Sustainability. 17(2). 472–472. 1 indexed citations

Cheng, R., et al.. (2025). Comparative Transcriptomics Analyses Identify DDX43 as a Cellular Regulator Involved in Suppressing HSV-2 Replication. Viruses. 17(10). 1366–1366.

Wang, Hongling, Xudong Wang, Yanwei Li, et al.. (2025). Neoadjuvant PD-1 inhibitor combined with Nab-paclitaxel and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NCT05522985): A randomized, controlled, open label, phase II clinical trial.. Journal of Clinical Oncology. 43(16_suppl). 6018–6018. 1 indexed citations

Wang, Hui, Xinhua Wang, Xiaoyang Zhou, et al.. (2023). 895P Neoadjuvant PD-1 inhibitor combined with Nab-paclitaxel and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NCT05522985): A randomized, controlled, open label, phase II clinical trial. Annals of Oncology. 34. S571–S572. 7 indexed citations

Meng, Hua, Xue Zhao, Shengyun Hu, et al.. (2021). [Clinical pathological features of 180 cases with primary esophageal malignant melanoma].. PubMed. 43(9). 949–954. 1 indexed citations

Cheng, R., et al.. (2020). [Therapeutic effect of nivolumab on non-small-cell lung cancer patients with brain metastases: a retrospective study].. PubMed. 42(11). 961–965. 1 indexed citations

Song, Xin, Xue Zhao, R. Cheng, et al.. (2018). The alterations of cytokeratin and vimentin protein expressions in primary esophageal spindle cell carcinoma. BMC Cancer. 18(1). 356–356. 8 indexed citations

Yoh, Kiyotaka, Yukio Hosomi, Tomohide Tamura, et al.. (2017). Ramucirumab in East Asian patients with stage IV non-small cell lung cancer after disease progression on platinum-based therapy: A pooled analysis of two randomized double-blind studies. Annals of Oncology. 28. x122–x122. 1 indexed citations

Zhao, Xue, Han Ma, Hui Meng, et al.. (2017). Shared susceptibility loci at 2q33 region for lung and esophageal cancers in high-incidence areas of esophageal cancer in northern China. PLoS ONE. 12(5). e0177504–e0177504. 5 indexed citations

10.

Song, Xin, et al.. (2017). Characterization of tissue chromogranin A (CgA) immunostaining and clinicohistopathological changes for the 125 Chinese patients with primary small cell carcinoma of the esophagus. Diseases of the Esophagus. 30(8). 1–7. 11 indexed citations

11.

Ong, Keat Khim, R. Cheng, Donald A. Tomalia, et al.. (2001). Dendrimer enhanced immunosensors for biological detection. Analytica Chimica Acta. 444(1). 143–148. 52 indexed citations

12.

Cheng, R., et al.. (1991). Evidence for a Role of Protein Kinase-C in His-D-Trp Ala-Trp-D-Phe-Lys-NH₂-Induced Growth Hormone Release from Rat Primary Pituitary Cells. Endocrinology. 129(6). 3337–3342. 111 indexed citations

13.

Cheng, R., et al.. (1989). The Synergistic Effects of His-D-Trp-Ala-Trp-D-Phe- Lys-NH₂on Growth Hormone (GH)-Releasing Factor- Stimulated GH Release and Intracellular Adenosine 3',5'-Monophosphate Accumulation in Rat Primary Pituitary Cell Culture. Endocrinology. 124(6). 2791–2798. 245 indexed citations

14.

Malchoff, Carl D., et al.. (1987). A Putative Mediator of Insulin Action Which Inhibits Adenylate Cyclase and Adenosine 3′,5′-Monophosphate- Dependent Protein Kinase: Partial Purificaton from Rat Liver: Site and Kinetic Mechanism of Action*. Endocrinology. 120(4). 1327–1337. 35 indexed citations

15.

Cole, Susan P.C., S E Mirski, R.C. McGarry, et al.. (1986). Differential expression of the Leu-7 antigen on human lung tumor cells. Lung Cancer. 2(4). 252–252. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact